risk
contamin
cell
line
raw
materi
emerg
virus
great
import
product
biopharmaceut
global
limit
flow
money
servic
good
peopl
across
geograph
boundari
also
includ
distribut
pathogen
nonindigen
locat
result
recent
decad
emerg
reemerg
virus
one
geograph
locat
anoth
one
suscept
host
anoth
observ
human
immunodefici
viru
sever
acut
respiratori
syndrom
coronaviru
middl
east
respiratori
syndrom
coronaviru
influenza
viru
type
hepat
viru
ebola
viru
west
nile
viru
wnv
zika
viru
zikv
exampl
viru
speci
whose
incid
geograph
spread
increas
past
year
could
diversifi
near
futur
develop
manufactur
biolog
advanc
therapi
medicin
product
atmp
employ
variou
cell
line
raw
materi
activ
pharmaceut
ingredi
api
human
anim
sourc
requir
sophist
safeti
assay
good
manufactur
practic
gmp
standard
potenti
viral
contamin
includ
emerg
virus
may
enter
biolog
product
process
cell
line
raw
materi
thu
pose
risk
downstream
applic
drug
safeti
risk
viral
contamin
must
therefor
mitig
stringent
test
appropri
stage
product
regulatori
guidelin
recommend
viral
safeti
test
outlin
requir
test
variou
stage
product
life
cycl
includ
raw
materi
cell
substrat
viru
seed
unprocess
bulk
harvest
end
product
zikv
emerg
arthropodborn
member
flavivirida
viru
famili
close
relat
mosquitoborn
arbovirus
dengu
viru
yellow
fever
viru
wnv
japanes
enceph
viru
introduct
zikv
america
highlight
epidem
potenti
global
public
health
burden
infect
zikv
major
healthi
human
asymptomat
progress
neurolog
complic
enceph
meningoenceph
syndrom
adult
birth
defect
fetal
neonat
microcephali
group
togeth
congenit
zika
syndrom
zikv
present
mani
countri
africa
asia
across
america
caus
truli
global
concern
despit
identif
zikv
report
presenc
africa
asia
mani
decad
littl
attent
paid
potenti
contamin
raw
product
human
anim
origin
use
manufactur
biolog
natur
zikv
circul
sylvat
cycl
involv
multipl
mosquito
speci
primarili
aed
famili
primat
natur
reservoir
speci
zikv
fig
predomin
transmiss
rout
zikv
human
occur
via
bite
infect
mosquito
although
nonvectorborn
rout
zikv
transmiss
document
includ
sexual
transmiss
blood
transfus
organ
transplant
perinat
transplacent
transmiss
infecti
zikv
particl
detect
saliva
blood
serum
semen
urin
infect
human
inde
broad
tropism
viru
persist
may
lead
longerterm
issu
affect
countri
result
zikv
may
enter
biopharmaceut
product
materi
viraem
yet
asymptomat
donor
donor
persist
replic
viru
urinari
tract
renal
system
possibl
persist
zikv
infect
multipl
tissu
recent
demonstr
rhesu
macaqu
model
therefor
raw
materi
human
origin
affect
area
consid
potenti
contamin
zikv
includ
limit
blood
blood
compon
plasma
platelet
convalesc
serum
monocyt
heterolog
cell
albumin
coagul
factor
immunoglobulin
urin
serv
sourc
pharmacolog
activ
substanc
human
chorion
gonadotropin
hcg
human
menopaus
gonadotropin
menotropin
hmg
folliclestimul
hormon
fsh
urokinas
limit
epidemiolog
surveil
evid
suggest
zikv
infect
wider
mammal
speci
may
possibl
studi
perform
indonesia
late
suggest
hors
cow
carabao
water
buffalo
goat
duck
bat
seroposit
antibodi
zikv
may
suggest
raw
materi
speci
may
harbour
pathogen
limit
natur
studi
lack
independ
correl
releg
risk
theoret
howev
worth
mention
even
monkey
ape
natur
reservoir
zikv
natur
experiment
infect
monkey
ape
demonstr
symptom
manifest
clinic
diseas
infect
zikv
furthermor
recent
report
zikv
replic
cell
line
nonhuman
primat
vero
pig
rabbit
hamster
chicken
clearli
suggest
wide
rang
anim
cell
line
relev
manufactur
biopharmaceut
may
suscept
zikv
line
report
goat
seroposit
antibodi
zikv
theoret
risk
introduct
zikv
contamin
pharmaceut
process
use
raw
materi
anim
origin
includ
clonal
select
cell
line
cell
sort
antibodi
antisera
anim
speci
goat
mitig
risk
viral
contamin
biolog
materi
test
vitro
assay
detect
adventiti
virus
use
sever
suscept
detector
cell
line
classic
report
cytopath
effect
cpe
haemadsorpt
haemagglutin
may
observ
recent
demonstr
schmallenberg
orthobunyaviru
emerg
viral
pathogen
cattl
sheep
detect
classic
vitro
adventiti
viru
assay
zikv
report
elicit
cpe
panel
continu
cell
line
lead
us
suggest
vitro
assay
util
appropri
cell
line
cpe
end
point
gmpcompliant
assay
platform
may
repres
suitabl
mean
ensur
robust
detect
zikv
biolog
materi
food
drug
administr
fda
european
pharmacopeia
ph
eur
world
health
organis
guidelin
qualif
cell
substrat
raw
materi
use
product
biolog
specifi
monolay
cultur
detector
cell
includ
cultur
speci
tissu
type
use
product
test
articl
addit
cultur
human
diploid
cell
line
monolay
cultur
anoth
cell
line
differ
speci
fda
requir
specifi
monkey
kidney
cell
line
use
therefor
purpos
studi
human
diploid
cell
line
atcc
ccl
secondari
african
green
monkey
kidney
cell
vero
atcc
atcc
challeng
two
strain
zikv
detector
cell
classic
vitro
adventiti
viru
biosafeti
assay
cell
line
use
studi
manufactur
thoroughli
character
gmp
condit
accord
guidelin
intern
confer
harmon
topic
ich
character
vero
cell
includ
confirm
cell
line
ident
assess
puriti
freedom
fungi
bacteria
steril
well
mycoplasma
adventiti
virus
test
human
diploid
cell
line
demonstr
cytopath
effect
cpe
inocul
zikv
african
lineag
viru
fig
b
tabl
structur
chang
host
cell
morpholog
cpe
form
retard
cell
growth
extens
cell
round
lysi
zikv
clearli
observ
inocul
zikv
report
major
well
day
post
inocul
pi
mean
appear
cpe
day
cell
demonstr
earli
sign
cpe
follow
inocul
zikv
day
post
infect
pi
cpe
observ
well
day
pi
mean
appear
cpe
day
inocul
zikv
cpe
report
day
pi
mean
appear
day
inocul
zikv
report
cpe
well
day
well
day
tabl
inocul
brazilian
isol
asian
lineag
zikv
level
detector
cell
line
elicit
cpe
well
respect
vitro
assay
tabl
fig
b
mean
appear
cpe
day
pi
day
supernat
inocul
onto
subconflu
monolay
cpe
observ
well
respect
day
cpe
vero
vero
cell
similar
observ
cell
present
structur
chang
host
cell
morpholog
retard
cell
growth
extens
cell
round
detach
lysi
vero
report
presenc
zikv
occas
day
vitro
assay
onset
cpe
observ
earli
day
pi
mean
appear
cpe
day
respect
zikv
elicit
cpe
vero
well
day
vitro
cultur
mean
appear
cpe
day
vero
detect
presenc
zikv
well
inocul
occas
vitro
assay
tabl
fig
f
inocul
zikv
elicit
cpe
vero
well
occas
day
vitro
assay
mean
appear
cpe
day
vero
detect
presenc
zikv
occas
day
vitro
assay
mean
appear
cpe
report
day
inocul
zikv
elicit
cpe
vero
well
occas
day
vitro
assay
inocul
zikv
report
cpe
well
day
tabl
fig
f
vero
detect
zikv
well
inocul
occas
well
inocul
zikv
well
inocul
vitro
assay
tabl
mean
appear
cpe
report
day
inoculum
day
day
vero
detect
zikv
well
inocul
occas
well
inocul
vitro
assay
tabl
fig
inocul
zikv
detect
occas
vitro
assay
zikv
inocul
cpe
inocul
vero
detector
cell
vitro
assay
inocul
cell
vitro
assay
tabl
fig
mean
appear
cpe
report
day
inoculum
day
day
day
inocul
detector
cell
measl
viru
bovin
parainfluenza
viru
type
repres
system
suitabl
control
vero
detector
cell
line
respect
elicit
clear
detect
occas
within
day
tabl
studi
address
use
classic
vitro
assay
cpe
endpoint
test
detect
zikv
contamin
biolog
ph
eur
section
recommend
cell
cultur
test
adventiti
viral
contamin
viral
vaccin
human
use
perform
minimum
day
furthermor
also
recommend
veterinari
vaccin
test
presenc
adventiti
virus
vitro
assay
minimum
day
cultur
ph
eur
section
studi
challeng
detector
cell
line
zikv
african
asian
lineag
vitro
assay
assess
standard
gmp
guidelin
adventiti
viru
test
report
gener
vitro
adventiti
viru
test
cpe
end
point
use
gmpcompliant
safeti
test
biolog
demonstr
suitabl
robust
reproduc
detect
detect
studi
singledigit
level
zikv
mani
flavivirus
caus
haemadsorpt
haemagglutin
certain
type
erythrocyt
although
address
studi
haemadsorpt
haemagglutin
endpoint
test
could
serv
suitabl
complementari
cpe
method
detect
zikv
follow
vitro
cultur
howev
haemagglutin
endpoint
test
known
concentr
depend
vitro
clear
unambigu
cpe
offer
robust
end
point
reli
speciesdepend
erythrocyt
select
divers
phenotyp
zikv
demonstr
african
strain
show
higher
infect
rate
asian
strain
vari
yield
viru
produc
human
neuron
cell
line
recent
report
context
qualiti
assur
gmp
complianc
therefor
also
import
assess
whether
strain
differ
origin
robustli
detect
variat
suscept
detector
cell
line
must
taken
account
assess
presenc
zikv
biolog
therefor
assess
suitabl
two
cell
line
human
diploid
african
green
monkey
vero
cell
line
detect
zikv
african
asian
lineag
cell
robustli
reproduc
detect
singledigit
level
zikv
wherea
inocul
zikv
detect
occas
order
assess
suitabl
vero
cell
detect
differ
lineag
zikv
test
two
subtyp
vero
cell
current
use
gmp
test
laboratori
first
vero
atcc
isol
african
green
monkey
chlorocebu
sp
refer
origin
vero
cell
second
vero
atcc
clone
vero
atcc
isol
vero
vero
cell
exhibit
slower
growth
rate
comparison
vero
show
contact
inhibit
thu
suitabl
propag
detect
slowli
replic
virus
virus
may
requir
sever
round
replic
becom
fit
detect
replic
cell
cultur
studi
vero
vero
cell
indic
presenc
zikv
strain
similar
manner
day
assay
zikv
detect
vero
vero
well
zikv
vero
vero
well
detect
isol
african
asian
lineag
level
approxim
infecti
viru
particl
observ
occas
inocul
well
vero
cell
line
day
inocul
approxim
infecti
viru
particl
indic
cpe
well
day
well
day
assay
tabl
data
show
test
presenc
zikv
biolog
requir
vero
cell
detect
zikv
contamin
robustli
reproduc
suitabl
level
sensit
acknowledg
strain
zikv
eg
central
asia
cambodia
thailand
may
show
vari
phenotyp
vitro
cultur
may
also
depend
innat
compet
cell
line
restrict
virus
howev
purpos
work
two
diverg
strain
repres
two
major
lineag
select
vero
cell
line
defici
synthesi
interferon
alpha
beta
ifn
host
immun
defenc
molecul
aim
restrict
viral
replic
wide
rang
arthropodborn
virus
includ
strain
dengu
type
west
nile
japanes
enceph
usutu
zikv
replic
elicit
cpe
vero
cell
importantli
due
abil
support
replic
wide
rang
flavivirus
vero
line
also
recommend
viru
stock
product
eu
horizon
zikalli
consortium
use
public
health
england
nation
collect
pathogen
virus
ncpv
gener
authent
stock
zikv
suppli
aim
present
studi
determin
whether
gener
valid
assay
vitro
adventiti
viru
assay
abl
detect
zikv
might
present
raw
materi
cell
line
use
product
biolog
demonstr
pathogen
robustli
detect
vitro
assay
therebi
provid
assur
detect
zikv
turn
underpin
robust
vitro
virolog
assay
safeti
test
biolog
importantli
matrix
product
may
inhibitori
viru
detect
assay
consequ
affect
sensit
detect
therefor
one
key
assess
biosafeti
test
finish
biolog
establish
level
effect
test
articl
matrix
gener
valid
assay
detect
contamin
studi
known
product
specif
qualif
psq
examin
quantit
effect
repres
batch
defin
product
process
perform
assay
matric
bulk
harvest
may
ostens
similar
may
quit
differ
behaviour
vitro
assay
psq
address
psq
normal
perform
phase
iii
clinic
develop
requir
part
biolog
licenc
applic
summari
demonstr
robust
detect
zikv
use
classic
vitro
assay
detect
adventiti
virus
vero
cell
demonstr
robust
detect
singl
digit
zikv
african
asian
lineag
vero
cell
classic
vitro
assay
cpe
endpoint
test
describ
studi
use
proactiv
evidencebas
approach
mitig
risk
zikv
contamin
raw
materi
cell
line
compon
use
manufactur
biolog
human
diploid
cell
line
ccl
secondari
african
green
monkey
kidney
cell
vero
obtain
american
type
cultur
collect
atcc
manufactur
thoroughli
character
bioreli
gmp
condit
accord
guidelin
intern
confer
harmon
topic
ich
character
vero
cell
includ
confirm
cell
line
ident
assess
puriti
freedom
fungi
bacteria
steril
well
mycoplasma
adventiti
virus
test
cell
lot
number
passag
cultur
highglucos
dulbeco
modifi
eagl
medium
hgdmem
gibco
supplement
foetal
clone
iii
hyclon
mm
lglutamin
gibco
mm
nonessenti
amino
acid
neaa
gibco
vero
lot
number
passag
vero
lot
number
passag
cell
cultur
hgdmem
fetal
bovin
serum
fb
gibco
titrat
subsequ
vitro
adventiti
viru
assay
detector
cell
line
maintain
eagl
minimum
essenti
medium
emem
gibco
supplement
fb
mm
lglutamin
mm
sodium
pyruv
gibco
u
penicillin
gibco
streptomycin
gibco
amphotericin
b
sigma
gentamicin
gibco
two
strain
zikv
use
studi
repres
african
asian
lineag
african
zikv
strain
abbrevi
isol
rhesu
monkey
zika
forest
uganda
zikv
obtain
bei
resourc
niaid
nih
genom
rna
zikv
viru
asian
lineag
zikv
strain
abbrevi
zikv
isol
patient
recif
brazil
produc
describ
previous
strain
character
avail
mrcunivers
glasgow
centr
viru
research
zikv
zikv
titrat
vero
cell
atcc
use
titrat
eight
replic
viru
dilut
viru
titrat
four
replic
perform
two
occas
mean
titr
obtain
zikv
zikv
bovin
parainfluenza
viru
type
measl
viru
edmonston
strain
obtain
atcc
measl
viral
stock
produc
titrat
accord
gmp
detector
cell
vero
atcc
vero
atcc
atcc
ccl
seed
cell
ml
growth
medium
hg
dmem
plate
monolay
health
confluenc
examin
continu
post
seed
medium
remov
cultur
cell
wash
approxim
mlwell
phosphat
buffer
salin
pb
gibco
neg
control
inocul
one
plate
per
cell
type
inocul
mainten
medium
emem
use
volum
ml
per
well
follow
incub
min
inoculum
remov
cultur
refe
ml
per
well
mainten
medium
emem
zikv
dilut
titr
per
ml
cultur
medium
one
plate
cell
type
inocul
dilut
viru
use
inoculum
volum
ml
per
well
follow
vero
vero
cell
inocul
either
zikv
zikv
separ
furthermor
cell
inocul
measl
viru
vero
cell
inocul
parainfluenza
viru
type
follow
incub
min
inoculum
remov
cultur
refe
mlwell
mainten
medium
cultur
maintain
minimum
period
day
examin
regularli
fed
least
per
week
day
supernat
well
exhibit
cpe
inocul
onto
fresh
detector
cell
blind
passag
neg
control
inocul
alongsid
harvest
supernat
follow
adsorpt
inocula
cultur
incub
day
total
day
period
cultur
examin
regularli
cpe
fed
least
per
week
appear
cpe
record
imag
taken
appropri
data
repres
inocul
perform
well
detector
cell
seed
plate
three
separ
occas
run
tabl
monolay
cell
run
maintain
day
blind
passag
day
monolay
cell
run
maintain
day
statist
analysi
outlier
perform
use
graphpad
onlin
grubb
test
signific
level
twotail
